About: Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2007 (uk) im Februar 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 2007 (ast) artikull shkencor i botuar më 01 shkurt 2007 (sq) scientific article published on 01 February 2007 (en)
publication date	wds:Q57086739-46AC7964-38FF-48C4-83F1-17FE74891F89
publication date	2007-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57086739-813CD4E2-8FFD-4A7C-9678-D919D190C020
language of work or name	English
cites work	wds:Q57086739-53FF0090-6A38-4B68-B726-AE02598DA303 wds:Q57086739-DE985EDD-2442-45EA-947F-82F3DADD3D87 wds:Q57086739-FD60BCF3-CDDA-4F53-BC90-B628ED4D2A90
cites work	The use of beta-agonists and the risk of death and near death from asthma Inflammatory bowel disease and the risk of fracture Inhaled corticosteroids and hip fracture
author name string	wds:Q57086739-CDDC7F51-4BFB-4F3E-B354-DC5CA79C9EAA wds:Q57086739-D4606843-589B-45BC-AF8F-44307E318720 wds:Q57086739-E72A6C2C-5EA9-4495-A91D-C1089FE1BB83 wds:Q57086739-F639DA1C-6C77-4873-9B88-9863B9170313
author name string	H G M Leufkens M Bracke S Pouwels J W J Lammers
rdfs:label	Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (en) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (nl) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (sq)
skos:prefLabel	Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (en) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (nl) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (sq)
name	Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (en) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (nl) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study (sq)
author	wds:Q57086739-198A9C99-8273-4094-B9EE-9B613E4E6CEB wds:Q57086739-3A371E0E-F6E0-4BC5-B380-7642DE94969C wds:Q57086739-B7E87F46-3318-401C-847D-FB1AF91DF83A
author	Cyrus Cooper Tjeerd P van Staa Frank de Vries
title	wds:Q57086739-1D7BBB7F-7A91-40BD-B33D-BD42759FE104
title	Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study (en)
page(s)	wds:Q57086739-0344B009-779F-4F34-82AD-14A1760B0BA0
page(s)	170-177
instance of	wds:Q57086739-B8F283D5-71C8-4BE6-B457-DA1DBBC3F309
instance of	scholarly article
main subject	wds:Q57086739-A5D8D290-0C08-4959-8099-F8BCF230CD81 wds:Q57086739-C376B917-F6E8-418A-8111-C68158BACE49
main subject	inflammation bone fracture
PubMed ID	wds:Q57086739-059F8B71-27ED-4D8C-8E55-34F650312BFD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17241182
PubMed ID	17241182
published in	wds:Q57086739-DA05A1B2-4102-4E40-97D2-F510EC698057
published in	Journal of Internal Medicine
issue	wds:Q57086739-0BBC3F5A-BCF9-42E7-8114-6CF15FB8470A
volume	wds:Q57086739-8FC90AA5-C940-4C31-9F90-5D544C45B367
issue	2
volume	261
DOI	wds:Q57086739-5A6C0CC0-D126-42D7-82B3-D290834DA7FD
DOI	http://dx.doi.org/10.1111/J.1365-2796.2006.01754.X
DOI	10.1111/J.1365-2796.2006.01754.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57086739
is cites work of	The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis Use of organic nitrates and the risk of hip fracture: a population-based case-control study Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study Knee arthroplasty and risk of hip fracture: a population-based, case-control study The risk of fracture in patients with multiple sclerosis: the UK general practice research database Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009]. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway. Curcumin alleviates glucocorticoid-induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro. Treatment of Pediatric Acute Graft-versus-Host Disease-Lessons from Primary Immunodeficiency? The Skeletal Effects of Inhaled Glucocorticoids Metabolic Disorders in Chronic Lung Diseases. Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment Long-term therapy in COPD: any evidence of adverse effect on bone? Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects The ability of H1 or H2 receptor antagonists or their combination in counteracting the glucocorticoid-induced alveolar bone loss in rats. Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: the need for standard audit guidelines Risk of cataract and glaucoma in patients with multiple sclerosis [Safety of inhaled corticosteroids in COPD] Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study. A soluble bone morphogenetic protein type 1A receptor fusion protein treatment prevents glucocorticoid-Induced bone loss in mice Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K/AKT pathways Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.
is cites work of	wds:Q34084507-38FD26BE-0A10-4CC0-B965-11F3FF005163

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software